Charity registration number SC036559 (Scotland)
Company registration number SC283423 (Scotland)
CURE CROHN'S COLITIS
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
CURE CROHN'S COLITIS
CONTENTS
Page
Trustees report
1 - 2
Independent examiner's report
3
Statement of financial activities
4
Balance sheet
5
Notes to the financial statements
6 - 10
CURE CROHN'S COLITIS
TRUSTEES REPORT (INCLUDING DIRECTOR'S REPORT)
FOR THE YEAR ENDED 30 APRIL 2025
- 1 -

The trustees present their annual report and financial statements for the year ended 30 April 2025.

The accounts have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the Charities and Trustee Investment (Scotland) Act 2005, the Charities Accounts (Scotland) Regulations 2006 (as amended), the provisions of the Charities SORP (FRS 102) “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (effective 1 January 2019) and provisions of the Companies Act 2006 applicable to small companies. Given the size of the entity it is the opinion of the directors that the information given below is sufficient to comply with the Statement of Recommended Practice.

Objectives and activities

The charity was founded with the sole objective of raising funds for patient centric research into inflammatory bowel disease ("IBD") in the UK. All fundraising is through private donations.

The trustees are actively looking at new projects to fund and further sums will be invested in the coming year.

The trustees are also continually looking to broaden the scope of the charity’s donor base and will, where appropriate, continue to work with other likeminded charities and bodies in order to meet the charity’s objectives.

Achievements and performance

During the year the charity made no grants (2024 - £62,000).

Financial review

The results for the year are as stated in the Statement of Financial Activities on page 4 and the balance sheet position on page 5.

At the year end the charity held reserves totalling £192,829 (2024 - £161,101). Reserves are held only until suitable research projects can be identified and the Trustees are satisfied that the identified research projects can be funded fully by the charity and its supporters and collaborators.

The Trustees are of the opinion that the funds held in reserve which are not already committed will be largely applied in the future as new projects are identified.

Risk management

The trustees have assessed the major risks to which the charity is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks.

Plans for future periods

The trustees will contintue to look for new projects to fund in order to assist in the research into inflammatory bowel disease.

Structure, governance and management

The charity is controlled by its governing document, memo and articles of association, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006.

The trustees, who are also the directors for the purpose of company law, who served during the year and up to the date of signature of the financial statements were:

D Gaya
E Gallacher
(Resigned 11 November 2025)
D Blance
G Tiefenbrun
M Cairns
(Appointed 31 January 2025)

The officer in charge of the day to day running of the charity is trustee Gilad Tiefenbrun.

CURE CROHN'S COLITIS
TRUSTEES REPORT (INCLUDING DIRECTOR'S REPORT) (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
- 2 -

All trustees are volunteers and may be assisted by other volunteers. There are no staff or other employees. Suitable trustees are recruited based on their skills and experience. A formal induction is held for new trustees which includes training on relevant regulation and trustees' responsibilities.

Reference and Administrative Details

Registered Company number

SC283423 (Scotland)

Registered Charity number

SC036559

Registered Office

Glasgow Road

Waterfoot

Eaglesham

Glasgow

G76 0EQ

Independant Examiner

Paul Hutchison ACA

Azets Audit Services

Quay 2

139 Fountainbridge

Edinburgh

EH3 9QG

The trustees r eport was approved by the Board of Trustees.

G Tiefenbrun
Trustee
9 January 2026
CURE CROHN'S COLITIS
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF CURE CROHN'S COLITIS
- 3 -

I report on the financial statements of the charity for the year ended 30 April 2025, which comprise the Statement of Financial Activities, Balance Sheet and related notes.

Respective responsibilities of trustees and examiner

The charity’s trustees, who are also the directors of Cure Crohn's Colitis for the purposes of company law, are responsible for the preparation of the financial statements in accordance with the terms of the Charities and Trustee Investments (Scotland) Act 2005 and the Charities Accounts (Scotland) Regulations 2006. The trustees consider that the audit requirement of Regulation 10(1)(a) to (c) of the 2006 Accounts Regulations does not apply. It is my responsibility to examine the financial statements as required under section 44(1)(c) of the Act and to state whether particular matters have come to my attention.

Basis of independent examiner's statement

My examination is carried out in accordance with Regulation 11 of the 2006 Accounts Regulations. An examination includes a review of the accounting records kept by the charity and a comparison of the financial statements presented with those records. It also includes consideration of any unusual items or disclosures in the financial statements, and seeks explanations from the trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently I do not express an audit opinion on the view given by the financial statements.

Independent examiner's statement

In the course of my examination, no matter has come to my attention:

(a)
which gives me reasonable cause to believe that in any material respect the requirements:
(i)

to keep accounting records in accordance with section 44(1) (a) of the 2005 Act and Regulation 4 of the 2006 Accounts Regulations; and

(ii)

to prepare financial statements which accord with the accounting records and comply with Regulation 8 of the 2006 Accounts Regulations;

have not been met; or

(b)

to which, in my opinion, attention should be drawn in order to enable a proper understanding of the financial statements to be reached.

Paul Hutchison ACA
Azets Audit Services
Chartered Accountants
Quay 2
139 Fountainbridge
Edinburgh
EH3 9QG
Dated: 15 January 2026
CURE CROHN'S COLITIS
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 30 APRIL 2025
- 4 -
Unrestricted
Unrestricted
funds
funds
2025
2024
Notes
£
£
Income from:
Donations and legacies
3
33,395
59,910
Investments
4
3,950
3,366
Total income
37,345
63,276
Expenditure on:
Charitable activities
5
5,551
63,575
Other
66
90
Total expenditure
5,617
63,665
Net income/(expenditure) for the year/
Net movement in funds
31,728
(389)
Fund balances at 1 May 2024
161,101
161,490
Fund balances at 30 April 2025
192,829
161,101

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.
CURE CROHN'S COLITIS
BALANCE SHEET
AS AT
30 APRIL 2025
30 April 2025
- 5 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
10
1,530
690
Cash at bank and in hand
191,299
160,411
192,829
161,101
Net current assets
192,829
161,101
Income funds
Unrestricted funds - general
192,829
161,101
192,829
161,101

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 30 April 2025.

The trustee s acknowledge their responsibilities for ensuring that the charity keeps accounting records which comply with section 386 of the Act and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its incoming resources and application of resources, including its income and expenditure, for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Trustees on 9 January 2026
G Tiefenbrun
Trustee
Company registration number SC283423
CURE CROHN'S COLITIS
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
- 6 -
1
Accounting policies
Charity information

Cure Crohn's Colitis is a private charitable company limited by guarantee incorporated in Scotland. The registered office is c/o Linn Products Limited, Glasgow Road, Eaglesham, Glasgow, G76 0EQ.

1.1
Accounting convention

The accounts have been prepared in accordance with the Charities and Trustee Investment (Scotland) Act 2005, the Charities Accounts (Scotland) Regulations 2006 (as amended), the provisions of the Charities SORP (FRS 102) “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (effective 1 January 2019), FRS 102 "the Financial Reporting Standard applicable in the UK and Republic of Ireland ("FRS 102") and the provisions of the Companies Act 2006 applicable to small companies. The charity is a Public Benefit Entity as defined by FRS 102.

The charity has taken advantage of the provision in the SORP not to prepare a Statement of Cash Flows.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4
Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

1.5
Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Liabilities are recognised as expenditure as soon as there is a legal of constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measure reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.

CURE CROHN'S COLITIS
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
1
Accounting policies
(Continued)
- 7 -
1.6
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through income and expenditure, are assessed for indicators of impairment at each reporting date. Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected.

If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in net income/(expenditure) for the year.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in net income/(expenditure) for the year.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the charity transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

CURE CROHN'S COLITIS
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
1
Accounting policies
(Continued)
- 8 -
Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future p aymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.

1.8
Taxation

The charity is exempt from corporation tax on its charitable activities.

2
Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The trustees are of the opinion that there are no critical accounting estimates or judgements that would have a material impact on the financial statements.

3
Donations and legacies
Unrestricted
Unrestricted
funds
funds
general
general
2025
2024
£
£
Donations and gifts
33,395
59,910
CURE CROHN'S COLITIS
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
- 9 -
4
Investments
Unrestricted
Unrestricted
funds
funds
general
general
2025
2024
£
£
Interest receivable
3,950
3,366
5
Charitable activities
2025
2024
£
£
Grant funding of activities (see note 6)
-
62,000
Raising funds
4,051
250
Share of governance costs (see note 7)
1,500
1,325
5,551
63,575
6
Grants payable
2025
2024
£
£
Grants to institutions:
University of Glasgow
-
50,000
Shape History
-
12,000
-
62,000
7
Support costs
Support costs
Governance costs
2025
2024
£
£
£
£
Raising funds
4,051
-
4,051
250
Independent examination fee
-
1,500
1,500
1,325
4,051
1,500
5,551
-
Analysed between
Charitable activities
4,051
1,500
5,551
1,575
CURE CROHN'S COLITIS
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
- 10 -
8
Trustees

None of the trustees (or any persons connected with them) received any remuneration, benefits or expenses from the charity during the year.

9
Employees
2025
2024
Number
Number
Total
0
0
There were no employees whose annual remuneration was more than £60,000.
10
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
1,530
690
11
Related party transactions

During the year, Linn Products Limited donated the independant examiners services fee of £1,500 (2024 - £1,325).

During the year the charity received donations totalling £22,916 (2024 - £18,366) from The Linn Foundation.

Charity trustee Gilad Tiefenbrun is a director of Linn Products Limited and a Trustee of The Linn Foundation.

2025-04-30 2024-05-01 false false CCH Software iXBRL Review & Tag 2025.2 SC283423 2024-05-01 2025-04-30 SC283423 bus:Director1 2024-05-01 2025-04-30 SC283423 bus:Director2 2024-05-01 2025-04-30 SC283423 bus:Director3 2024-05-01 2025-04-30 SC283423 bus:Director4 2024-05-01 2025-04-30 SC283423 bus:Director5 2024-05-01 2025-04-30 SC283423 2025-04-30 SC283423 2024-04-30 SC283423 2023-05-01 2024-04-30 SC283423 bus:FRS102 2024-05-01 2025-04-30 SC283423 char:IndependentExaminationCharity 2024-05-01 2025-04-30 SC283423 bus:FullAccounts 2024-05-01 2025-04-30 xbrli:pure xbrli:shares iso4217:GBP